Comparative Pharmacology
Head-to-head clinical analysis: M V C 9 3 versus M V I PEDIATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V C 9 3 versus M V I PEDIATRIC.
M.V.C. 9+3 vs M.V.I. PEDIATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
M.V.C. 9+3 is a multivitamin supplement providing essential vitamins and minerals that serve as cofactors in various metabolic reactions, including energy production, DNA synthesis, and cellular function. The specific components include B-vitamins (thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, biotin, folic acid, cyanocobalamin, ascorbic acid) and vitamins A, D, E, and K, which act as antioxidants, support immune function, and are required for normal growth and development.
Multivitamin preparation providing essential vitamins (A, C, D, E, K, B1, B2, B3, B5, B6, B7, B9, B12) as cofactors for enzymatic reactions, antioxidant functions, and maintenance of normal metabolic processes.
1 vial (10 mL) intravenously over at least 30 minutes daily, or as directed by vitamin and mineral requirements.
Intravenous infusion: 5 mL (1 vial) added to appropriate IV fluid, administered over 30 minutes daily.
None Documented
None Documented
Variable per component: thiamine 1-2 h, pyridoxine 15-20 h, cyanocobalamin 6 days (plasma); clinical depletion: weeks to months for stores.
Variable; vitamin A: 9-25 days (stored in liver), vitamin D: 2-3 weeks (fat-soluble), vitamin C: 10-20 hours (renal function dependent), B-complex: 1-10 hours. Clinical context: accumulation risk in renal impairment.
Renal: 10-70% (B vitamins, ascorbic acid, electrolytes); fecal: minimal (trace unabsorbed components). Biliary: negligible.
Renal: 60-80% (free vitamins), Biliary/fecal: 10-20% (unabsorbed and metabolites).
Category C
Category C
Multivitamin
Multivitamin